EastWest Bioscience Inc.
HBOSF
OTC PK
| 04/30/2022 | 01/31/2022 | 10/31/2021 | 07/31/2021 | 04/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -267.16% | 1,118.22% | -63.86% | -257.14% | 55.74% |
| Total Depreciation and Amortization | -18.93% | -10.86% | -10.76% | -13.17% | 28.57% |
| Total Amortization of Deferred Charges | 13.58% | 32.94% | 55.41% | 83.05% | 37.29% |
| Total Other Non-Cash Items | 660.90% | -17,770.37% | -291.41% | 189.91% | -245.27% |
| Change in Net Operating Assets | -27.13% | 344.77% | 356.67% | 157.07% | 6.98% |
| Cash from Operations | -107.05% | 82.49% | 108.24% | -240.69% | 218.72% |
| Capital Expenditure | 100.00% | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | -74.03% | 94.08% |
| Total Debt Issued | -100.00% | -93.23% | -- | 100.46% | -96.97% |
| Total Debt Repaid | 100.00% | 100.00% | 0.00% | -101.29% | 98.81% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 10,188.19% | -- |
| Cash from Financing | -100.00% | 1,730.72% | -140.56% | 3,430.65% | -85.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -104.69% | -57,415.38% | -13.37% | 3,566.82% | 62.92% |
